Lovenox and Duricef drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lovenox (enoxaparin sodium) and Duricef (cefadroxil/cefadroxil hemihydrate). Common drug interactions include cellulitis among females and pleural effusion among males.
The phase IV clinical study analyzes what interactions people have when they take Lovenox and Duricef. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Lovenox?
Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.
What is Duricef?
Duricef has active ingredients of cefadroxil/cefadroxil hemihydrate. eHealthMe is studying from 579 Duricef users. Check the latest studies of Duricef.
12 people who take Lovenox and Duricef together, and have interactions are studied.

What are the common drug interactions of Lovenox and Duricef, by gender? *:
female:
- Cellulitis (infection under the skin)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Abdominal pain
- Abdominal wall infection
- Acute respiratory failure
- Anaemia (lack of blood)
- Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
- Blood glucose increased
- Clostridium colitis (inflammation of colon by clostridium difficile bacteria infection)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
male:
- Pleural effusion (water on the lungs)
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Renal cyst (kidney cyst)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Ascites (accumulation of fluid in the abdominal cavity)
- Haemolytic uraemic syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more)
- Oedema peripheral (superficial swelling)
- Anaemia (lack of blood)
- Anisocytosis (patient's red blood cells are of unequal size)
- Atelectasis (partial or complete collapse of the lung)
What are the common drug interactions of Lovenox and Duricef, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Anaemia (lack of blood)
- Ascites (accumulation of fluid in the abdominal cavity)
- Haemolytic uraemic syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more)
- Oedema peripheral (superficial swelling)
- Abdominal pain
- Abdominal wall infection
- Anisocytosis (patient's red blood cells are of unequal size)
- Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
- Atelectasis (partial or complete collapse of the lung)
- Blood glucose increased
50-59:
- Acute respiratory failure
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Haematochezia (passage of stools containing blood)
- Interstitial lung disease
- Sepsis (a severe blood infection that can lead to organ failure and death)
60+:
- Cellulitis (infection under the skin)
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Renal cyst (kidney cyst)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Fall
- Fatigue (feeling of tiredness)
- Haemarthrosis (haemarthrosis is where blood is able to enter the joint capsule)
- Hypotension (abnormally low blood pressure)
- Loss of consciousness
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
What are the existing conditions these people have? *
- High Blood Pressure: 6 people, 50.00%
- Pain: 5 people, 41.67%
- Stress And Anxiety: 4 people, 33.33%
- Dyspnea (difficult or laboured breathing): 4 people, 33.33%
- Cellulitis (infection under the skin): 4 people, 33.33%
- Vitamin B1 Decreased: 3 people, 25.00%
- Laxative Supportive Care: 3 people, 25.00%
- Dyslipidaemia (abnormal amount of lipids): 3 people, 25.00%
- Gastric Ulcer (stomach ulcer): 3 people, 25.00%
- High Density Lipoprotein Decreased: 3 people, 25.00%
* Approximation only. Some reports may have incomplete information.
Do you take Lovenox and Duricef?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lovenox and Duricef:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lovenox:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Duricef:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lovenox and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Duricef and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on enoxaparin sodium and cefadroxil/cefadroxil hemihydrate (the active ingredients of Lovenox and Duricef, respectively), and Lovenox and Duricef (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Allopurinol cause Sprains? - now
- Could Micardis cause Purpura? - 5 seconds ago
- Drug interactions of Lotensin and Nexavar - 6 seconds ago
- Surmontil vs. Topamax, side effect and effectiveness comparison - 13 seconds ago
- Drug interactions of Medrol and Ropinirole Hydrochloride - 24 seconds ago
- Could Catapres cause Muscle Spasticity? - 24 seconds ago
- Could Zestoretic cause Chills? - 28 seconds ago
- Drug interactions of Duragesic-100 and Cubicin - 31 seconds ago
- Could Promethazine cause Regurgitation? - 35 seconds ago
- Could Valtrex cause Visual Acuity Reduced? - 37 seconds ago